New Hampshire bill would allow rabies titer exemptions

New Hampshire is weighing a rabies policy change that would be unusual in companion animal medicine: House Bill 1488 would let certain dogs, cats, and ferrets avoid required booster shots if they qualify for an annual exemption based on rabies antibody titer testing. The proposal, sponsored by Rep. Keith Ammon, keeps the initial vaccination requirement in place, but opens a new route for pet parents who want to rely on laboratory evidence of immune response instead of scheduled revaccination. (legiscan.com)

The bill appears to have grown out of constituent concerns about vaccine adverse effects and the difficulty of obtaining medical exemptions under current law. New Hampshire already requires dogs, cats, and ferrets older than 3 months to receive rabies vaccination, with revaccination between 9 and 12 months after the initial dose and then boosters according to the NASPHV Compendium of Animal Rabies Prevention and Control. Under HB 1488, that framework would remain, but lawmakers would add a second exemption pathway beyond the existing medical waiver process. (legiscan.com)

The introduced bill is more specific than many early summaries suggest. It says a local rabies control authority could issue an exemption either with the written recommendation of a veterinarian, an ACVIM diplomate, and the state veterinarian, or with the written recommendation of a single licensed veterinarian who performs titer testing under the bill’s standards. Those standards require a baseline titer before vaccination, a second titer 7 to 14 days after vaccination to establish that individual animal’s immune response, and future titer results that are equal to or higher than that post-vaccination baseline. Animals exempted for medical reasons would still face strict isolation, leash, and muzzle restrictions, while animals exempted through titers would not. (legiscan.com)

That distinction is one reason the proposal is drawing scrutiny. The NASPHV rabies compendium states that rabies antibody titers indicate a response to vaccine or infection, but “do not directly correlate with protection,” and says circulating rabies antibodies in animals should not be used as a substitute for current vaccination when managing exposures or deciding on booster needs. AAHA’s canine vaccination guidelines take the same position, saying serologic testing is not considered a substitute for vaccination because protective correlates have not been established for rabies. In other words, the bill would create a legal exemption based on a measure that major veterinary and public health guidance does not accept as equivalent to current vaccination. (nasphv.org)

Industry and media coverage has also highlighted the cost and access issues built into the proposal. Vet Candy reported that rabies titer testing for this purpose could run about $300 to $500 and noted that only a limited number of U.S. laboratories perform the testing. That means the bill would not simply create a clinical alternative, it would create a paid exemption pathway that may be more accessible to some pet parents than others. (myvetcandy.com)

Why it matters: For veterinary teams, the biggest issue is not whether titers have any biologic meaning, but whether they can safely replace the legal and public health function of rabies revaccination. Rabies rules sit at the intersection of companion animal care, bite management, shelter medicine, municipal enforcement, and human exposure prevention. If a state recognizes titer-based exemptions, clinics may need new protocols for medical records, certificates, client education, and exposure counseling, especially because national guidance still treats overdue animals with positive titers as not currently vaccinated for many regulatory purposes. That could also create friction with boarding facilities, groomers, insurers, and interstate or international movement rules that still look for a valid rabies certificate, not a titer result. (nasphv.org)

There’s also a broader signal here for the profession. Even if HB 1488 does not pass as introduced, it reflects a familiar pressure point: pet parents asking for more individualized vaccine decisions, especially after suspected adverse events, while public health frameworks remain population-based and deliberately conservative. Veterinary professionals may increasingly be asked to explain the difference between immunologic evidence, legal vaccination status, and exposure management, particularly as titer testing becomes more visible to clients. (aaha.org)

What to watch: Watch for committee action, amendments that narrow the exemption, and any formal response from state veterinary or public health stakeholders, because the bill’s fate may hinge on whether lawmakers view titers as a clinical accommodation or as a public health risk. (citizenscount.org)